President’s letter
2020 Metrics
Cycle of Translation
Visionary Gifts
Discovery to Clinic
Innovative Education
Translational Luminaries
Introduction
The Ann Kimbell and John W. Johnson Center for Cellular Therapeutics
The Fondren Food & Health Alliance and The Fondren Inflammation Center
Cockrell Center for Advanced Therapeutics
Paula and Joseph C. “Rusty” Walter III Translational Research Initiative
Jerold B. Katz Academy of Translational Research
result
Outcomes Research
Precision Medicine
CPRIT Funding to Drive New Discoveries in Cancer Therapeutics
Siemens Healthineers and Houston Methodist Imaging Innovation Hub Empowers Researchers to Push the Boundaries
Novel Monoclonal Antibody Treatment Halts Tumor Growth in Deadly Ovarian and Pancreatic Cancers
Houston Methodist Institute for Technology, Innovation & Education (MITIESM)
Can Devices Provide A New Treatment Option for Glioblastoma?
Houston Methodist Hospital’s new Paula and Joseph C. “Rusty” Walter III Tower offers the Most advanced treatments and innovations available
Neuroimaging Offers New Insights into Neurodegeneration
COVID-19 Studies
Restorative Medicine
Houston Methodist and Rice University Launch Center for Translational Neural Prosthetics and Interfaces
Non-invasive Spinal Stimulation Enables Paralyzed People to Stand Unassisted
Dissolvable Implants Enhance the Body’s Ability to Heal Broken Bones
Cell Encapsulation May Hold the Key to Preventing Cell Transplant Rejection
Revolutionizing the Future of Complex Valve Disease Management
Science in Service
of
Medicineresult
President's letter
2020 Metrics
Cycle of Translation
Visionary Gifts of Hope
Introduction
The Ann Kimbell and John W. Johnson Center for Cellular Therapeutics
The Fondren Food & Health Alliance and The Fondren Inflammation Center
Cockrell Center for Advanced Therapeutics
Paula and Joseph C. “Rusty” Walter III Translational Research Initiative
Jerold B. Katz Academy of Translational Research
From Discovery to Clinic
Introduction
Restorative Medicine
Houston Methodist and Rice University Launch Center for Translational Neural Prosthetics and Interfaces
Non-invasive Spinal Stimulation Enables Paralyzed People to Stand Unassisted
Dissolvable Implants Enhance the Body’s Ability to Heal Broken Bones
Cell Encapsulation May Hold the Key to Preventing Cell Transplant Rejection
Revolutionizing the Future of Complex Valve Disease Management
Precision Medicine
CPRIT Funding to Drive New Discoveries in Cancer Therapeutics
An Innovative New Tool to Enable Drug Discovery and Personalized Medicine
Devising a Novel Combination Treatment for Aggressive Double-hit Lymphoma
Expanding the RNAcore to Encompass the Entire Cycle of a Cure
Siemens Healthineers and Houston Methodist Imaging Innovation Hub Empowers Researchers to Push the Boundaries
Novel Monoclonal Antibody Treatment Halts Tumor Growth in Deadly Ovarian and Pancreatic Cancers
Houston Methodist Institute for Technology, Innovation & Education (MITIESM)
Surgical Technology Developed in MITIE Gains FDA Approval
Pushing the Frontier of the Robotics Revolution
Can Devices Provide A New Treatment Option for Glioblastoma?
Houston Methodist Hospital’s new Paula and Joseph C. “Rusty” Walter III Tower offers the Most advanced treatments and innovations available
Neuroimaging Offers New Insights into Neurodegeneration
Translational Luminaries
Innovative Education
Neural Control of Organ Degeneration and Regeneration (NeuralCODR) Training Program
Neural Control of Organ Degeneration and Regeneration (NeuralCODR) Training Program
Share this story
The NeuralCODR training program is an interdisciplinary training program at the intersection of neurophysiology and organ engineering/modeling that investigates how the central nervous system communicates with other organ systems.
The training program can be distinguished from traditional physiology or neuroscience programs by its strategic focus on the interface between regeneration/disease organ model systems and functional neuroanatomy and physiology.
NeuralCODR was conceived by Philip Horner, PhD, and a team of expert faculty from across several Texas Medical Center institutions with a rich history of research training, clinical modelling and education including Rice University, University of Houston, University of Texas MD Anderson Cancer Center, UT Health Science Center at Houston and Baylor College of Medicine.
The 2020 NeuralCODR Fellows
Caroline Cvetkovic, PhD
For her NeuralCODR fellowship in Robert Krencik PhD’s lab, Cvetkovic is investigating the relationship between astrocytes and neurons in the brain. She is developing human stem-cell derived 3D neural tissue cultures to gain deeper insights into neuronal development and degeneration that could someday lead to regenerative clinical therapies.
Betsy Salazar
As a NeuralCODR fellow under the guidance of Alvaro Munoz, PhD and Timothy Boone, MD, PhD, Salazar is investigating the impact of therapeutic drugs on functional recovery following spinal cord injury in rodent models. She is specifically interested in assessing motor function recovery using behavioral tests as well as assessing the
impact that treatments have at the cellular level.
More from Innovative Education